4/A
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-048861
Chairman and CEO bought 30,000 shares at an average $2.65 ($79,418)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +4,100 | $2.63 | $10,783 | 10,197,393 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +25,900 | $2.65 | $68,635 | 10,223,293 | D |
| Open-market purchases · 30,000 sh · avg $2.65 · $79,418 | |||||||
Loading xslF345X03/doc4a.xml…